-
effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
August 01, 2020 - or complex
presentations of dementias.
2
affects about 5 million U.S. adults 65 years … of Alzheimer's disease
and related dementias in the United States
(2015-2060) in adults aged >65 years
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
January 01, 2012 - system is intended
to identify interventions that purport to address an unmet need and are up to 7 years … out on the
horizon and then to follow them for up to 2 years after initial entry into the health care … Topics eligible for
inclusion are those interventions expected to be within 0–4 years of potential … ES-3
Although AD is potentially fatal, patients can live as long as 20 years after diagnosis and often … The anticipated doubling of the number of people aged 65 years and older by 2040
portends an increase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
September 20, 2013 - Food and Drug Administration (FDA) to treat
irritability in children 5 to 16 years of age with ASD.48 … adaptive behavior when the intervention was delivered over substantial
intervals of time (i.e., 1–2 years … Question 1
Among children ages 0–12 years who have ASD, what are the short- and long-term effects of … Question 2
Among children ages 0–12 years, what are the modifiers of outcome for different treatments … The population of
interest is patients 0–12 years diagnosed with ASD.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - Globally, asthma ranks 14th based on the
burden of disease, as measured by disability adjusted life years … not well defined, though, the maintenance dose is typically
given once or twice monthly for 3 to 5 years … Through the years, various chemical modifications of allergens have been attempted to enhance
efficacy … For studies with pediatric patients, we will present results, where possible, by
the categories: 0-4 years … old, 5-11 years old and older than 12 years old1
o Grouping by asthma severity and asthma control
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - Recognition of potential benefits of
breastfeeding in recent years has resulted
in a renewed interest … What are the benefits of various treatments for
ankyloglossia in children through 18 years of age intended … Analytic framework for ankyloglossia in infants and children through18 years of age
Children with … ankyloglossia
or with
ankyloglossia
tight labial
frenula ages 0 to
18 years
Harms (Key
Questions … = 18; control
group).16 The frenotomy group performed better than
the no-frenotomy group at age 3 years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Introduction The USPSTF and many other organizations suggest starting
screening at age 40 years of age … We are
aware that 2 years is commonly suggested in the
literature; however, requiring 2 years would … certainly comes from pooling
data from studies that may have differed in many
small details such as years … Results p. 42 “within the last five years” is too vague. … The authors should
specify the years to aid readers using this report a decade later.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
March 13, 2013 - )
Children with neurodevelopmental delays during their early years may eventually be diagnosed with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
January 01, 2009 - scan of the literature for randomized, controlled, and observational trials published in the
last ten years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
February 10, 2010 - The final proposed KQs for this review are:
Question 1
In adults and children 5 years of age … Question 2
In adults and children 5 years of age and older with asthma, does the use of breathing … PICOTS
Population • Adults and children 5 years of age and older with asthma of any
type or severity … with asthma
of any type and severity,
symptomatic or using asthma
medication
Children >5 years … diagnosis by medical
practitioner (self-report of physician
diagnosis acceptable)
Children <5 years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
October 01, 2006 - ; the majority of
published studies on stent placement in ARAS had
followup duration of less than 2 years … differences in mortality rates, no differences in
mortality were found between interventions, up to about
5 years … Very high mortality rates, over 40 percent
within 6 years, occurred mostly in studies of patients
with … single cohort study of medical
treatment reported change in serum creatinine over an
average of 1.5 years … , and 31 cohort
studies of various interventions suggest no difference in mortality
up to about 5 years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
May 01, 2008 - Together with
influenza, pneumonia constitutes the fifth leading cause of death in those age 65 years … The
incidence of hospitalization for pneumonia for those age 65 years and older in the US increased … case-control study was nested) was all up-to-standard person-time
occurring in individuals age 65 years … Trends in
hospitalizations for pneumonia among persons aged
65 years or older in the United States, … of hospitalization for pneumonia
Cases
(N = 12,044)
Controls
(N = 48,176)
median age in years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - better than not screening for CRC and that the age
to begin screening in average-risk adults is 50 years … Force (USPSTF), agree that
the recommended options in screening for CRC include: colonoscopy every 10 years … testing (FOBT) or fecal immunohistochemical testing (FIT)
annually; and flexible sigmoidoscopy every 5 years … PICOTS
Population Asymptomatic adults at average risk for CRC, who are age 40 years or older
( … Inclusion/Exclusion criteria
Category Inclusion/Exclusion Criteria
Population KQs 1-6: Adults ≥40 years
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
December 01, 2013 - system
is intended to identify interventions that purport to address an unmet need and are up to 3 years … out
on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for
inclusion are those interventions expected to be within 0–3 years of potential … its student health center in 2010, charging $25
for each dose of Plan B One-Step® for students 17 years … health center in
2010, charging $25 for each dose of Plan B One-Step® (levonorgestrel) for students 17 years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - National Health and Nutrition Examination Surveys in 2005–
2006 estimated that 29 percent of all adults 18 years … Vasan and colleagues report a lifetime risk of developing hypertension within adults aged
55–65 years … • Studies must evaluate adherence rates based on predictors (e.g., age group ≥65
vs. <65 years old … ), not predictor values based on adherence (e.g., adherers were
on average X years old and nonadherers … were on average Y years old).
-
effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
January 01, 2012 - system is intended to identify
interventions that purport to address an unmet need and are up to 7 years … out on the horizon and then to
follow them for up to 2 years after initial entry into the health care … Topics eligible for inclusion
are those interventions expected to be within 0 to 4 years of potential … Buprenorphine falls into the Schedule III class of drugs
under the Controlled Substances Act of 1970.
6
For years … a health systems perspective, noted that the injection, which has been on the
market for several years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
July 01, 2009 - Its prevalence increases with age,
from 0.1 percent in people under 55 years
to more than 9 percent by … 80 years of age. … There is a high level of evidence to show that age,
within the approximate range of 40 to 70 years, is … suggest that only a small proportion of
patients included in the analyses were younger than
about 40 years … or older than about 70 years.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Among Medicare
beneficiaries age 85 years or older,
sulfonylureas were used more
frequently than both … It is strongly
associated with obesity and age over 45 years. … a
sulfonylurea, compared with a low of less
than 18 percent of beneficiaries under
the age of 45 years … The years were chosen based on the
availability of Medicare Part D in 2006.
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
January 01, 2012 - system is intended
to identify interventions that purport to address an unmet need and are up to 7 years … out on the
horizon and then to follow them for up to 2 years after initial entry into the health care … Topics eligible for
inclusion are those interventions expected to be within 0–4 years of potential
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
December 01, 2015 - system
is intended to identify interventions that purport to address an unmet need and are up to 3 years … out
on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for
inclusion are those interventions expected to be within 0–3 years of potential … Patients with IPF have a median life expectancy of
2–3 years from initial diagnosis, and no approved … the ASCEND trial and
another phase III trial suggest that pirfenidone’s benefit continued after 2 years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - Public Comment -
David Ahlquist
Executive
Summary
Comment ES 3-T3-2 ….Persons 65 years of age and … Public Comment -
Barry Berger
Executive
Summary
Comment ES 3-T3-2: ….Persons 65 years of age and … This test is expected to be available within the next
couple of years. … Evidence for optimal screening intervals is
generated over years of clinical experience with newly … This test is expected to be available within the next
couple of years.